1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 1: 
Background of the patients
Primary StrokeRecurrent StrokeP
Patients, n (M/F)102 (57/45)54 (38/16).0777
Age, yr (SD)69.0 (12.7)68.6 (11.4).8377
Hypertension, n (%)65 (63.7)38 (70.4).4045
Atrial fibrillation, n (%)14 (13.7)5 (9.3).4171
Diabetes mellitus, n (%)23 (22.5)9 (16.7).3867
Hyperlipidemia, n (%)20 (19.6)10 (18.5).8695
Intracranial large-artery disease, n (%)38 (37.3)16 (29.6).3409
Leukoaraiosis, grade (SD)1.04 (0.91)1.74 (0.99)<.0001
  • Note.—M indicates male; F, female.